Product Information
QC MUCUS RLF DM 20-400 MG CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0819 per EA under NDC 83324019550. Its NADAC has been published 87 times since Feb 5, 2025.
Strength
20; 400 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324019550
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/14/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MUCUS RLF DM 20-400 MG CPLT has been published 87 times since Feb 5, 2025, and over the history we have for it it has risen 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0819 per EA |
|---|---|
| All-time high | $0.0819 (Sep 30, 2026) |
| All-time low | $0.0771 (Jun 18, 2025) |
| 52-week high | $0.0819 |
| 52-week low | $0.0779 |
| Median price | $0.0786 |
| Average price | $0.0786 |
| Largest weekly change | +3.1% (Sep 23, 2026) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan Hydrobromide / Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC MUCUS RLF DM 20-400 MG CPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RLF DM 20-400 MG CPLT, manufactured by Chain Drug Marketing Association, is $0.0819 per EA (NDC 83324019550), effective Sep 30, 2026.
How has the price of QC MUCUS RLF DM 20-400 MG CPLT changed over time?
Over the history we have for it, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has risen 3.8%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC MUCUS RLF DM 20-400 MG CPLT?
Since Feb 5, 2025, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has ranged from a low of $0.0771 (Jun 18, 2025) to a high of $0.0819 (Sep 30, 2026), with a median of $0.0786 per EA.
Are there cheaper alternatives to QC MUCUS RLF DM 20-400 MG CPLT?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 7% below QC MUCUS RLF DM 20-400 MG CPLT.
Who manufactures QC MUCUS RLF DM 20-400 MG CPLT?
QC MUCUS RLF DM 20-400 MG CPLT (NDC 83324019550) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.